| |
Classification of the PSP |
|
Type of Patient Safety Practice
|
Safe
|
| |
|
Clinical Practice (CP)
|
Related practices from PaSQ database
|
| "Best fit" category of the reported practice |
|
Infection control / Prevention of surgical site infections
There is no specified text here
There is no specified text here
|
| Topic of the reported practice |
|
Clinical risk management
|
|
Aim and the benefit of the Patient Safety Practice
|
| |
To estimate the prevalence of latent tuberculosis infection (LTBI) and calculate
the main risk-factors associated with this condition in a cohort of healthcare students, either attending or not attending medical wards, trained at a large regional university hospital in Italy, a country at low incidence of tuberculosis (TB).
|
|
Description of the Patient Safety Practice
|
| |
In a cross-sectional study, students attending the Medical, Nursing, Paediatric Nursing and Midwifery Schools were actively called to undergo the Tuberculin Skin Test (TST). All TST positive cases were also tested with an Interferon-Gamma Release Assay (IGRA) to confirm the diagnosis of LTBI. Data regarding age, sex, nationality, health status and Bacille Calmette-Guérin (BCG) vaccination were collected for risk-assessment analysis.
Out of 881 subjects actively called for TB screening, 733 (83.2%) regularly performed TST. Prevalence of TST positives was 1.4%, and LTBI diagnosis, confirmed by IGRA, was performed in 0.5% of the study sample. BCG immunization (less than 2%) was not associated with a positive TST result. Furthermore, no difference in the risk of developing LTBI emerged between pre-clinical and clinical students, and the main independent variable associated with this status was to be born in a country with a high TB incidence (20 cases per 100,000 population) (adjusted OR= 32.35; 95%CI:2.71-386.73, p= 0.006 for IGRA positivity)
The project is easily transferable/reproducible in other hospitals and universities.
Indeed, it was based on an initial update of the protocols for screening, periodic monitoring and case management of latent tuberculosis infection in health care workers and students on the basis of the information provided by the Ministry of Health.
The screening and periodic monitoring are based upon the use of a cheap and easy-to-use test, the Mantoux screening test, and the collection of anamnestic data of healthcare workers and students who underwent screening.
The project transferability should be further underpinned by a specific Recommendation issued by the Ministry of Health, regarding the performance of such activities on both the healthcare workers and their equivalents, including health professionals in training.
|
| Attachment of relevant written information and/or photos, as appropriate |
There is no specified text here
There is no specified text here
There is no specified text here
There is no specified text here
|
|
Effectiveness of the Patient Safety Practice
|
| |
| Degree of implementation of reported practice |
|
Yes, fully
|
| Level of implementation of reported practice |
|
Institution level
|
| Specific and measurable outcome for the reported practice were defined |
|
Yes
|
| A baseline measurement before implementation of the reported practice was obtained |
|
Yes
|
| A measurement after full implementation of the reported practice was obtained |
|
Yes
|
| Evaluation of a "positive" effect of the reported practice on Patient Safety |
|
The evaluation showed improvements in Patient Safety outcomes
|
| Type of before-and after evaluation |
|
Quantitative
|
| Enclosure of a reference or attachment in case of published evaluation's results |
There is no specified text here
There is no specified text here
|
|
Health care context where the Patient Safety Practices was implemented
|
| |
|
Hospital
|
|
Transferability
|
| |
| Successful implementation of this Patient Safety Practice in other health care settings than above stated |
|
No
|
| Specification of implementation in another health care setting(s) |
|
There is no specified text here
|
| Successful implementation's level of this Patient Safety Practice across settings |
|
There is no specified text here
|
|
Involved health care staff
|
| |
Physicians
Quality manager
Risk manager
|
|
Patient Involvement
|
| |
| Direct service user's involvement as integral part of this Patient Safety Practice |
|
No
|
| Specification of the service users or their representatives' involvement in the implementation of this Patient Safety Practice |
|
There is no specified text here
|
| Point of time in which service user or their reprasentatives' involvement takes place |
|
There is no specified text here
|
| Active seeking of service users' opinion, feedback, experience, etc. as integral part of this Patient Safety Practice |
|
There is no specified text here
|
| Short description of the service users' level of involvement |
|
There is no specified text here
|
| Public accessibility of information regarding this Patient Safety Practice to patients and citizens/service users |
|
Yes
|
| List of sources where public information is accessible |
|
http://buonepratiche.agenas.it/practicesedit.aspx?id=4486
|
|
Implementation of the Patient Safety Practice
|
| |
| Existing collaboration with other countries or international organisations related to implementation of this Patient Safety Practice |
|
No
|
| Problems encountering in the implememntation course of this Patient Safety Practice like lack of motivation, no management support, etc. |
|
No
|
| List of the most prevelent difficulties encuntered during implementation of this Patient Safety Practice |
|
There is no specified text here
|
| List of the most prevalent drivers for a successful implemetation of this Patient Safety Practice |
|
Motivated staff
|
| Use of any specific incentives to enhance motivation while implementing this Patient Safety Practice |
|
No
|
| Description of used incentives, if any. |
|
There is no specified text here
|
| Existence of support or approval by the clinical or hospital management or any other hihg level authority in the implementation process of this Patient Safety Practice |
|
Yes
|
|
Costs of the Patient Safety Practices
|
| |
| Completion of cost calculation related to this Patient Safety Practice |
|
No
|
| Total number of person days required to implement this Patient Safety Practice |
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
|
| Total number of person days required for training as preparation for implementation of this Patient Safety Practice |
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
|
| Total cost in Euro of specific equipment (machines, software, communications supplies, etc.) needed to support implementation of this Patient Safety Practice |
|
There is no specified text here
|
| Associated cost with a work reduction or foregoing in order to deliver this Patient Safety Practice |
|
There is no specified text here
|
|
Contact information
|
| |
Name: Marzia Tomellini
Country: ITALY
Organisation: ISTITUTO NAZ. PER LA RICERCA SUL CANCRO
E-mail: marzia.tomellini@hsanmartino.it
Phone: There is no specified text here
|
|
|